Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Chromocell Therapeutics Corp (CHRO)
NYSE MKT:CHRO
Holding CHRO?
Track your performance easily
Chromocell Therapeutics Corp (CHRO) Ownership Overview
19.73% Insiders
0.08% Mutual Funds
0.78% Other Institutional Investors
79.41% Public Companies and
Individual Investors
The ownership structure of Chromocell Therapeutics Corp (CHRO) stock is a mix of institutional, retail, and individual investors. , 19.73% is owned by Insiders, and 79.41% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Sep 16, 2024 | Richard Malamut Director | xxxxxxxxxxxxx | $9776 |
| Sep 16, 2024 | Knuettel Francis Ceo, Pres., Cfo, Treas & Secty | xxxxxxxxxxxxx | $5044 |
| Sep 12, 2024 | Knuettel Francis Ceo, Pres., Cfo, Treas & Secty | xxxxxxxxxxxxx | $10955 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 547,710 | Insider | 9.09% | 345,605 | |
| 520,719 | Insider | 8.64% | 328,574 | |
| 91,565 | Insider | 1.52% | 57,778 | |
| 29,167 | Insider | 0.48% | 18,404 | |
| 5,011 | Institution | 0.08% | 3,162 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,011 | Institution | 0.08% | 3,162 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Chromocell Therapeutics Corp (CHRO)?
According to the latest TipRanks data, approximately 0.78% of the company's stock is held by institutional investors, 19.73% is held by insiders, and 79.41% is held by retail investors.
What percentage of Chromocell Therapeutics Corp (CHRO) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.78% of Chromocell Therapeutics Corp (CHRO) stock is held by institutional investors.
What percentage of Chromocell Therapeutics Corp (CHRO) stock is held by retail investors?
According to the latest TipRanks data, approximately 79.41% of Chromocell Therapeutics Corp (CHRO) stock is held by retail investors.
Who owns the most shares of Chromocell Therapeutics Corp (CHRO)?
Knuettel Francis owns the most shares of Chromocell Therapeutics Corp (CHRO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.